Exane Derivatives’s Appian APPN Stock Holding History
Bought
Maintained
Sold
Other funds holding APPN
ACA
SP
Exane Derivatives's APPN Position: Q2 2022 in Review
Exane Derivatives reduced its Appian (APPN) stake by 98% in Q2 2022, selling an estimated $153K and leaving 59 shares worth $2.79K. The position accounts for ﹤0.01% of the portfolio, ranked #414.
Exane Derivatives first reported a position in APPN in Q4 2021 and has held it in 3 quarters since. The position peaked at $223K in Q4 2021. 242 funds tracked by Wall St. Rank hold APPN as of Q2 2022.
- Exane Derivatives held 59 shares of Appian worth $2.79K as of Q2 2022.
- Exane Derivatives sold 3,045 Appian shares in Q2 2022, an estimated $153K.
- Appian made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #414 holding.
- Exane Derivatives first reported a position in Appian in Q4 2021 and has held it in 3 quarters since.
- Exane Derivatives's Appian position peaked at $223K in Q4 2021.
- 242 funds tracked by Wall St. Rank held Appian as of Q2 2022.
Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.